Intravenous DNase I clinical trials

Intravenous DNase I for the Treatment of Sepsis (IDEALSepsisI)

This study is looking at a new treatment called DNase I for people very sick with sepsis in intensive care. We want to see if it's safe, how much to give, and what effects it has on the body. This is an early-stage study to gather important information.